These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29226317)

  • 41. Singapore and the Nanyang Technological University--A young country with a young university on the move.
    Andersson B; Mayer T
    Biointerphases; 2010 Sep; 5(3):FA9-14. PubMed ID: 21171719
    [No Abstract]   [Full Text] [Related]  

  • 42. Global coalition chips away at neglected tropical diseases.
    Maxmen A
    Nature; 2017 Apr; 544(7650):281-282. PubMed ID: 28426009
    [No Abstract]   [Full Text] [Related]  

  • 43. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
    Snyder HM; Bain LJ; Egge R; Carrillo MC
    Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367
    [No Abstract]   [Full Text] [Related]  

  • 44. Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa.
    Gutierrez MM; Pillai G; Felix S; Romero F; Onyango KO; Owusu-Agyei S; Asante KP; Barnes KI; Sinxadi P; Allen E; Abdulla S; Masimirembwa C; Munyoro M; Yimer G; Gebre-Mariam T; Spector J; Ogutu B
    Clin Pharmacol Ther; 2017 Nov; 102(5):786-795. PubMed ID: 28378903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reforming science: methodological and cultural reforms.
    Casadevall A; Fang FC
    Infect Immun; 2012 Mar; 80(3):891-6. PubMed ID: 22184414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interest in partnerships around the Mediterranean basin for rare diseases].
    Mégarbané A
    Presse Med; 2012 May; 41 Suppl 1():S51-4. PubMed ID: 22459993
    [No Abstract]   [Full Text] [Related]  

  • 47. Policy forum: European policy. Interesting times--biology, European science, and EMBL.
    Kafatos FC
    Science; 2000 Feb; 287(5457):1401, 1403. PubMed ID: 10722387
    [No Abstract]   [Full Text] [Related]  

  • 48. Don't let Europe's open-science dream drift.
    Nature; 2017 Jun; 546(7659):451. PubMed ID: 28640285
    [No Abstract]   [Full Text] [Related]  

  • 49. Omic profiling for drug safety assessment: current trends and public-private partnerships.
    Gallagher WM; Tweats D; Koenig J
    Drug Discov Today; 2009 Apr; 14(7-8):337-42. PubMed ID: 19340928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Text-mining and information-retrieval services for molecular biology.
    Krallinger M; Valencia A
    Genome Biol; 2005; 6(7):224. PubMed ID: 15998455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Capacity building: Architects of South American science.
    Arzt E; Orjeda G; Nobre C; Castilla JC; Barañao L; Ribeiro S; Bifano C; Krieger JE; Guerrero PC
    Nature; 2014 Jun; 510(7504):209-12. PubMed ID: 24926500
    [No Abstract]   [Full Text] [Related]  

  • 52. Future directions in intergovernmental relations.
    Baracskay D
    J Health Hum Serv Adm; 2013; 36(2):252-69. PubMed ID: 24350555
    [No Abstract]   [Full Text] [Related]  

  • 53. The retention of forensic DNA samples: a socio-ethical evaluation of current practices in the EU.
    Van Camp N; Dierickx K
    J Med Ethics; 2008 Aug; 34(8):606-10. PubMed ID: 18667650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Open access to scientific research: where are we and where are we going? Facts and figures on the occasion of the 2010 Open Access Week (October 18-24).
    Giglia E
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):461-9. PubMed ID: 20927012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Data for the masses.
    Nature; 2009 Jan; 457(7226):129. PubMed ID: 19129801
    [No Abstract]   [Full Text] [Related]  

  • 56. Partnerships: beyond the buzzword.
    Freire MC
    Sci Transl Med; 2014 Jun; 6(242):242ed15. PubMed ID: 24964987
    [No Abstract]   [Full Text] [Related]  

  • 57. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 58. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Public-private partnerships to address innovation stakes of both industrialized and limited income countries].
    Bonneville M
    Med Sci (Paris); 2018 Oct; 34(10):763-764. PubMed ID: 30451662
    [No Abstract]   [Full Text] [Related]  

  • 60. Public-private partnerships for health--what does the evidence say?
    Thomason J; Rodney A
    P N G Med J; 2009; 52(3-4):166-78. PubMed ID: 21877579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.